Clinical trials
Recruiting Phase 4 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 12 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 3 |
| Eli Lilly and Company | 3 |
| Novartis Pharmaceuticals | 3 |
| OCEAN-SHD Study Group | 2 |
| Sanofi | 2 |
| Asan Medical Center | 1 |
| Chiba University | 1 |
| GlaxoSmithKline | 1 |
| Janssen Research & Development, LLC | 1 |
| Juntendo University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, Non-Hodgkin | 2 |
| Multiple Myeloma | 2 |
| Acute Coronary Syndrome | 1 |
| Adrenal Insufficiency | 1 |
| Angina, Stable | 1 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Aortic Valve Stenosis | 1 |
| Arthritis, Rheumatoid | 1 |
| Atypical Hemolytic Uremic Syndrome | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.